Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Deoxypodophyllotoxin triggers necroptosis in human non-small cell lung cancer NCI-H460 cells.

Wu M, Jiang Z, Duan H, Sun L, Zhang S, Chen M, Wang Y, Gao Q, Song Y, Zhu X, Zhang L.

Biomed Pharmacother. 2013 Oct;67(8):701-6. doi: 10.1016/j.biopha.2013.06.002. Epub 2013 Jul 4.

PMID:
23896261
2.

Deoxypodophyllotoxin induces G2/M cell cycle arrest and apoptosis in SGC-7901 cells and inhibits tumor growth in vivo.

Wang YR, Xu Y, Jiang ZZ, Guerram M, Wang B, Zhu X, Zhang LY.

Molecules. 2015 Jan 20;20(1):1661-75. doi: 10.3390/molecules20011661.

3.

Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.

Xue X, Sun DF, Sun CC, Liu HP, Yue B, Zhao CR, Lou HX, Qu XJ.

Lung Cancer. 2012 Jun;76(3):300-8. doi: 10.1016/j.lungcan.2011.12.013. Epub 2012 Jan 17.

PMID:
22261315
4.

Deoxypodophyllotoxin triggers parthanatos in glioma cells via induction of excessive ROS.

Ma D, Lu B, Feng C, Wang C, Wang Y, Luo T, Feng J, Jia H, Chi G, Luo Y, Ge P.

Cancer Lett. 2016 Feb 28;371(2):194-204. doi: 10.1016/j.canlet.2015.11.044. Epub 2015 Dec 9.

PMID:
26683770
5.

Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways.

Wu SH, Hang LW, Yang JS, Chen HY, Lin HY, Chiang JH, Lu CC, Yang JL, Lai TY, Ko YC, Chung JG.

Anticancer Res. 2010 Jun;30(6):2125-33.

PMID:
20651361
6.

Podophyllotoxin acetate triggers anticancer effects against non-small cell lung cancer cells by promoting cell death via cell cycle arrest, ER stress and autophagy.

Choi JY, Hong WG, Cho JH, Kim EM, Kim J, Jung CH, Hwang SG, Um HD, Park JK.

Int J Oncol. 2015 Oct;47(4):1257-65. doi: 10.3892/ijo.2015.3123. Epub 2015 Aug 13.

7.

Role of autophagy in apoptosis induction by methylene chloride extracts of Mori cortex in NCI-H460 human lung carcinoma cells.

Park SH, Chi GY, Eom HS, Kim GY, Hyun JW, Kim WJ, Lee SJ, Yoo YH, Choi YH.

Int J Oncol. 2012 Jun;40(6):1929-40. doi: 10.3892/ijo.2012.1386. Epub 2012 Feb 22.

PMID:
22367066
8.

Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects.

Jiang Z, Wu M, Miao J, Duan H, Zhang S, Chen M, Sun L, Wang Y, Zhang X, Zhu X, Zhang L.

Int J Biochem Cell Biol. 2013 Aug;45(8):1710-9. doi: 10.1016/j.biocel.2013.04.030. Epub 2013 May 20.

PMID:
23702033
9.

A1E inhibits proliferation and induces apoptosis in NCI-H460 lung cancer cells via extrinsic and intrinsic pathways.

Bak Y, Ham S, Baatartsogt O, Jung SH, Choi KD, Han TY, Han IY, Yoon DY.

Mol Biol Rep. 2013 Jul;40(7):4507-19. doi: 10.1007/s11033-013-2544-0. Epub 2013 May 7.

PMID:
23649764
10.

Anti-cancer effect of tectochrysin in NSCLC cells through overexpression of death receptor and inactivation of STAT3.

Oh SB, Hwang CJ, Song SY, Jung YY, Yun HM, Sok CH, Sung HC, Yi JM, Park DH, Ham YW, Han SB, Hwang BY, Hong JT.

Cancer Lett. 2014 Oct 10;353(1):95-103. doi: 10.1016/j.canlet.2014.07.007. Epub 2014 Jul 30.

PMID:
25083589
11.

Antitumor activity of AZ64 via G2/M arrest in non-small cell lung cancer.

Xue Y, Ren H, Xiao W, Chu Z, Lee JJ, Mao L.

Int J Oncol. 2012 Nov;41(5):1798-808. doi: 10.3892/ijo.2012.1619. Epub 2012 Sep 4.

PMID:
22948297
12.
13.

Antitumor activity of noscapine in human non-small cell lung cancer xenograft model.

Jackson T, Chougule MB, Ichite N, Patlolla RR, Singh M.

Cancer Chemother Pharmacol. 2008 Dec;63(1):117-26. doi: 10.1007/s00280-008-0720-z. Epub 2008 Mar 13.

PMID:
18338172
14.

Shikonin circumvents cancer drug resistance by induction of a necroptotic death.

Han W, Li L, Qiu S, Lu Q, Pan Q, Gu Y, Luo J, Hu X.

Mol Cancer Ther. 2007 May;6(5):1641-9.

15.

Synergistic action by multi-targeting compounds produces a potent compound combination for human NSCLC both in vitro and in vivo.

Zhang C, Zhai S, Li X, Zhang Q, Wu L, Liu Y, Jiang C, Zhou H, Li F, Zhang S, Su G, Zhang B, Yan B.

Cell Death Dis. 2014 Mar 20;5:e1138. doi: 10.1038/cddis.2014.76.

16.

In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.

Fahham D, Weiss ID, Abraham M, Beider K, Hanna W, Shlomai Z, Eizenberg O, Zamir G, Izhar U, Shapira OM, Peled A, Wald O.

J Thorac Cardiovasc Surg. 2012 Nov;144(5):1167-1175.e1. doi: 10.1016/j.jtcvs.2012.07.031. Epub 2012 Aug 24.

17.

Autophagy inhibition enhances isorhamnetin‑induced mitochondria‑dependent apoptosis in non‑small cell lung cancer cells.

Ruan Y, Hu K, Chen H.

Mol Med Rep. 2015 Oct;12(4):5796-806. doi: 10.3892/mmr.2015.4148. Epub 2015 Jul 29.

18.

[Inhibitory effects of a combination of rmhTRAIL and gemcitabine on human non-small cell lung cancer cell line NCI-H460 cells in vitro and in vivo].

Tang CH, Liu XQ, Yang SF, Zhu B, Gao HJ.

Zhonghua Zhong Liu Za Zhi. 2008 Nov;30(11):808-12. Chinese.

PMID:
19173823
19.

Human positive coactivator 4 is a potential novel therapeutic target in non-small cell lung cancer.

Peng Y, Yang J, Zhang E, Sun H, Wang Q, Wang T, Su Y, Shi C.

Cancer Gene Ther. 2012 Oct;19(10):690-6. doi: 10.1038/cgt.2012.52. Epub 2012 Aug 24.

PMID:
22918472
20.

Gallic acid induces apoptosis via caspase-3 and mitochondrion-dependent pathways in vitro and suppresses lung xenograft tumor growth in vivo.

Ji BC, Hsu WH, Yang JS, Hsia TC, Lu CC, Chiang JH, Yang JL, Lin CH, Lin JJ, Suen LJ, Gibson Wood W, Chung JG.

J Agric Food Chem. 2009 Aug 26;57(16):7596-604. doi: 10.1021/jf901308p.

PMID:
20349925
Items per page

Supplemental Content

Write to the Help Desk